Trial Details

COMPLETED
Basic Information
Clinical ID c877
Identifier NCT03710486
Trial Title A Study to Observe Vedolizumab and Anti-tumour Necrosis Factors (Anti-TNFs) Outcomes in Real-world Biologic Ulcerative Colitis (UC) and Crohn's Disease (CD) Participants
Trial URL Visit Original Page
Study Information
Study Results

YES

Conditions Colitis, Ulcerative|Crohn Disease
Interventions -
Participant Information
Sponsor Takeda
City Santa Maria da Feira
Country/Region Portugal
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type OBSERVATIONAL
Phase -
Time Information
Start Date 2019-02-19
Primary Completion Date 2021-08-23
Completion Date 2022-02-21